Latest News

 Filter by Provider

Wells raised GOOGL stock to overweight, lifting the price target to 387 from 354.

While Synopsys has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Chip stocks may get all of the attention, but this company is gaining share in AI data centers.

AMAT's Quality score hits 90.89 after a Q1 earnings beat. 49.1% margins and AI growth landed Applied Materials in the top 10% of stocks.

Real estate data provider CoStar Group (NASDAQ:CSGP) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.

Specialty insurance company Bowhead Specialty Holdings (NYSE:BOW) will be announcing earnings results tomorrow before market hours. Here’s what to look for.

TOMI (TOMZ) shares rise after receiving approval for its BIT solution in Great Britain. Stock is 8.33% above 20-day SMA.

Portland General Electric delivers power to nearly a million Oregon customers, leveraging a diversified generation and transmission network.

Heading into earnings, quantum computing stocks have struggled.

AI stocks have been volatile in 2026. Earnings reports this week from Nvidia, CoreWeave, Snowflake and Salesforce could decide what's next.

Apple (AAPL) and Transocean (RIG) reported positive news, while analysts remain bullish on AppLovin (APP) and Microsoft (MSFT) for the year.

Don't bank too heavily on a strategy that may not meet your needs.

Gold advanced, and the U.S. dollar weakened after a U.S. Supreme Court ruling fueled fresh uncertainty over tariffs imposed by President Donald Trump.

Gilead Sciences to acquire Arcellx for $7.8B, gaining full control of promising CAR T-cell therapy for cancer.

Net product revenue in the fourth quarter surged 431% to $38.3 million, above estimates of $37.8 million, according to Fiscal.ai data

Carrying credit card debt? A 0% balance transfer card can pause interest and save you thousands faster than consolidation loans.

Home Depot (NYSE: HD) is expected to report Q4 earnings of $2.53 per share on Feb. 24. Analysts lowered price target to $363, but potential dividend gains may appeal to investors.

Axon Enterprise has markedly lagged the broader market over the past year, but analysts remain strongly bullish on the stock’s outlook.

Assurant has trailed the S&P 500 over the past year, but analysts still see a constructive path forward and remain moderately bullish on the stock’s outlook.

According to TheFly, Wedbush’s Dan Ives cited investment price discipline as the reason for the removal of PANW from the list.

Ameriprise Financial has meaningfully lagged the broader market over the past year, though analysts have become cautiously bullish on the stock’s outlook.

Chipotle Mexican Grill has lagged the broader market over the past year, but analysts remain constructive on the stock’s longer-term outlook.

Novo's next-gen drug CagriSema didn't match weight loss from Eli Lilly's Zepbound.

Avery Dennison has meaningfully trailed the broader market over the past year, but analysts remain moderately bullish on the stock’s outlook.

Novo Nordisk investors get a second bite at the Ozempic apple.

While the crypto market sentiment has reached extreme fear, analyst Van de Poppe sees the growing gap between gold and Bitcoin as an opportunity to buy the dip.

Crypto investors have, by one measure, never been this panicked before.

He said he can use licenses to do absolutely “terrible” things, especially to those countries that have been ripping off the U.S. for many decades.

Faraday Future (NASDAQ: FFAI) announced strategic adjustments to prioritize production and delivery of its vehicles and EAI Robotics systems.